Flowers Foods FLO Q4 2025 Earnings Surprise EPS 022 Up Significant Bill Ackman Takes Microsoft Stake Echoing Jim Cramers Bullish View on Competitive Flexibility Reviva RVPH Delivers Q3 2025 Beat EPS 120 vs 198 Expected Cineverse CNVS Slips 157 Testing 238 Support 20260518 SpaceX Successfully Launches Starship on Second Attempt in Latest Test Flight Ethical Hacker and CBSE Clash Over Exam Portal Data Breach Claims UK Intelligence Chief Warns of Moment of Consequence as RussiaChina Threats Mount Market Implications Steel Stocks Rally After Government Extends Minimum Import Price on 66 Steel Products UK Exports to US Plunge 25 as Trump Tariffs Reshape Trade Balance Exodus Expands XO Swap Reach Through Bitget Wallet Integration Crane Company CR Q1 2026 Earnings EPS Beat Drives Modest Stock Gains Amid Mixed Operating Trends TCMD Q1 2026 Earnings NarrowerThanExpected Loss Signals Operational Progress CVGI Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment ICHR Q1 2026 Earnings EPS Beat Surprises Revenue Details Omitted FSUN Q1 2026 Earnings EPS Misses Estimates Despite Solid Operating Performance Newmark Group NMRK Q1 2026 Earnings EPS Surges Past Estimates with 18 Beat Enveric Biosciences ENVB Drops 4 as Stock Nears Key Support at 203 Central Pacific Financial CPF Shows Modest Gain Testing Upper Range NiSource Inc NI Holds Near Support as Utility Sector Faces Mixed Signals NL Industries Inc NL Surges 12 Analyzing the Big Move T Stamp Inc IDAI Shows Modest Gains as Price Approaches Key Resistance WST Q1 2026 Earnings EPS Surges 2578 Past Estimates Driving Positive Market Reaction MFC Q1 2026 Earnings EPS Misses Estimates Amid Subdued Market Reaction REX Q3 2001 Earnings EPS Surpasses Estimates by 23 Lyell Immunopharma Q1 2026 Earnings Narrower Loss Beats Estimates as Pipeline Progress Continues EPAM Q1 2026 Earnings EPS Beats Estimates Stock Edges Higher Amid Cautious Outlook JOE Q1 2026 Earnings Reported EPS of 024 Amid Quiet Quarter Shares Edge Lower China Industrial Profits Surge 247 in April Fastest Gain in Over Two Years Edgewise Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Clinical Progress Continues Dynamix Corporation Warrant ETHMW Holds Steady at 017 as Consolidation Continues